Company type | Privately held |
---|---|
Industry | Medical technology |
Founded | 2000 |
Founder | Gust Bardy, MD and Riccardo Cappato, MD |
Defunct | June 8, 2012[1] |
Fate | Acquired |
Successor | Boston Scientific |
Headquarters | San Clemente, California, United States |
Key people | Kevin Hykes, President and CEO |
Products | Subcutaneous Implantable cardioverter-defibrillator |
Website | www.cameronhealth.com |
Cameron Health was a medical device developer based in San Clemente, California, US. Cameron Health had its European office, Cameron Health BV, in Arnhem, The Netherlands. The privately held company's focus was on a new generation of minimally invasive implantable cardioverter-defibrillator (ICD) which they called a Subcutaneous Implantable Defibrillator (S-ICD). Cameron Health's approach avoided implanting transvenous leads into the heart, which had been the usual procedure for cardiac devices. Instead, the Cameron ICD was entirely implanted outside the thoracic wall.
In June 2012, Boston Scientific acquired Cameron Health for a total sum of $1.3 Billion, paid out incrementally as various revenue milestones were achieved.[1] As of February 2016[update], Boston Scientific still markets the S-ICD system.[2]